1.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: 70 and under Sponsor: NCI Protocol IDs: EST-PE-179
|
|
2.
|
Phase: Phase III Type: Treatment Status: Closed Age: pre-/perimenopausal Sponsor: Protocol IDs: CAN-NCIC-MA12, NCI-V93-0323, NCT00002542, MA12
|
|
3.
|
Phase: Phase III Type: Treatment Status: Closed Age: 35 to 80 Sponsor: Protocol IDs: GER-AIO-02/92, EU-93010
|
|
4.
|
Phase: Phase III Type: Treatment Status: Closed Age: pre/postmenopausal Sponsor: Protocol IDs: SCTN-BR9403, EU-94004, NCT00002579
|
|
5.
|
Phase: Phase III Type: Treatment Status: Closed Age: Not specified Sponsor: Protocol IDs: NCRI-ABC, CRC-TU-BR3010, SCTN-BR9401/BR9402, YRCO-ABC, EU-94029, UKCCCR-ABC, NCT00002582
|
|
6.
|
Phase: Phase III Type: Treatment Status: Closed Age: over 16 Sponsor: Protocol IDs: IBCSG-IX, EU-94040
|
|
7.
|
Phase: Phase III Type: Treatment Status: Closed Age: pre/perimenopausal 30 and over Sponsor: Protocol IDs: CNR-GROCTA-010209, EU-93018
|
|
8.
|
Phase: Phase III Type: Treatment Status: Closed Age: 20 to 65 Sponsor: Other Protocol IDs: YALE-HIC-7996, NCI-V95-0728
|
|
9.
|
Phase: Phase III Type: Treatment Status: Temporarily closed Age: 21 to 75 Sponsor: Other Protocol IDs: GOCS-08-BR-95-III, NCI-F95-0036, NCT00002696
|
|
10.
|
Phase: Phase III Type: Treatment Status: Closed Age: over 18 Sponsor: Protocol IDs: SCTN-BR9405, EU-95048, NCT00002755
|
|
11.
|
Phase: Phase III Type: Treatment Status: Closed Age: 16 to 65 Sponsor: Protocol IDs: IBCSG-15-95, EU-96021, NCT00002784
|
|
12.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 70 and over Sponsor: NCI Protocol IDs: CCCWFU-98195, NCI-V96-1082
|
|
13.
|
Phase: Phase III Type: Treatment Status: Closed Age: Not specified Sponsor: Protocol IDs: SCTN-BR9601, EU-97013, NCT00003012
|
|
14.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 to 70 Sponsor: Other Protocol IDs: INT-23/96, EU-97001, NCT00003013
|
|
15.
|
Phase: Phase III Type: Treatment Status: Closed Age: Not specified Sponsor: Other Protocol IDs: CRC-TU-NEAT, EU-98041, NCT00003577
|
|
16.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 to 60 Sponsor: Protocol IDs: SCTN-BR9810, EU-98054, NCT00003680
|
|
17.
|
Phase: Phase III Type: Treatment Status: Closed Age: Not specified Sponsor: Other Protocol IDs: CRC-TU-BR3015, EU-99005, NCT00003893
|
|
18.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 to 70 Sponsor: Protocol IDs: BIG-2-98, ABCSG-BIG-2-98, BREAST-BIG-2-98, DBCG-BIG-2-98, GOCCHI-BIG-2-98, IBCSG-BIG-2-98, ICORG-BIG-2-98, SBCG-BIG-2-98, EU-20002, RP-56976-V-315, NCT00005659
|
|
19.
|
Phase: Phase III Type: Treatment Status: Closed Age: 65 and over Sponsor: NCI Protocol IDs: CALGB-49907, ECOG-CALGB-49907, CAN-NCIC-MAC1, SWOG-CALGB-49907, NCT00024102, MAC1
|
|
20.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-7732
|
|
21.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 to 75 Sponsor: Protocol IDs: POA-74379, WFU-74379
|
|
22.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-82-C-129, NCI-MB-164, NCI-T83-1159N, T83-1159
|
|
23.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: SEG-76BRE303, SEG-76BRE0103
|
|
24.
|
Phase: Phase III Type: Treatment Status: Completed Age: postmenopausal under 70 Sponsor: NCI Protocol IDs: CLB-7682, CALGB-7682
|
|
25.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: SEG-BRE-83307R-T
|